Express Scripts to Buy Medco for $29 Billion

Thomson Reuters Ownership Intelligence offers free access to industry reports, investor profiles, job movements of investment professionals, and much more. Follow them on Twitter.

Express Scripts Inc (ESRX-O) will buy rival Medco Health Solutions (MHS-N), joining together two of the Big 3 pharmacy benefit managers. The $29 billionprice tag consists of cash and stock, but it still needs to gain regulatory approval which may be difficult. Upon completion of the deal, ESRX shareholders willown 59% of the combined company, leaving 41% to MHS holders.

This report identifies the largest institutional investors of both companies.